Literature DB >> 31286390

Assessment of the expression level of miRNA molecules using a semi-quantitative RT-PCR approach.

Shima Andoorfar1, Seyed Ali Hosseini Tafreshi2, Zahra Rezvani1.   

Abstract

Type 2 diabetes is one of the most prevalent diseases, which increases resistance to insulin in target tissues. The measurement of miRNAs quantity is a molecular approach for diagnosis of diabetes. miRNAs are small non-coding RNA strings of 21-23 long nucleotides that act as inhibitors in proteins translation. Several methods including Northern blot, qRT-PCR and Microarray have been used for diagnosis of miRNA molecules. Real time PCR is an expensive and accurate quantitative method that is widely used in miRNA studies. The miR-21 is an important miRNA in diabetes. In this study, for the first time, a semi-quantitative protocol was developed to quantify different amounts of a synthetic miR-21. In addition to semi-quantitative method, the miR-21 quantity was determined by quantitative method in several patients with type 2 diabetes and healthy people. The results indicated that there was a direct relationship between the amount of synthetic miR-21 and the intensity of the PCR bands. We also showed that the expression of miR-21 in people with type 2 diabetes increased compared to healthy people. The results were observed by both quantitative and semi-quantitative methods. The real-time RT-PCR was more sensitive than semi-quantitative PCR in identification of miRNAs. However, semi-quantitative PCR method benefited from higher simplicity and lower costs for defining general patterns of miRNA expression.

Entities:  

Keywords:  Real-time RT-PCR; Semi-quantitative PCR; Type 2 diabetes; miR-21

Mesh:

Substances:

Year:  2019        PMID: 31286390     DOI: 10.1007/s11033-019-04959-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  12 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

Review 2.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 3.  Gestational diabetes mellitus.

Authors:  Thomas A Buchanan; Anny H Xiang
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 4.  Biosensors for cancer markers diagnosis.

Authors:  Ibtisam E Tothill
Journal:  Semin Cell Dev Biol       Date:  2009-02-04       Impact factor: 7.727

Review 5.  Detection methods for microRNAs in clinic practice.

Authors:  Mariàngels de Planell-Saguer; Maria Celina Rodicio
Journal:  Clin Biochem       Date:  2013-03-13       Impact factor: 3.281

Review 6.  Circulating microRNAs as novel biomarkers for diabetes mellitus.

Authors:  Claudiane Guay; Romano Regazzi
Journal:  Nat Rev Endocrinol       Date:  2013-04-30       Impact factor: 43.330

7.  Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes.

Authors:  Anna Zampetaki; Stefan Kiechl; Ignat Drozdov; Peter Willeit; Ursula Mayr; Marianna Prokopi; Agnes Mayr; Siegfried Weger; Friedrich Oberhollenzer; Enzo Bonora; Ajay Shah; Johann Willeit; Manuel Mayr
Journal:  Circ Res       Date:  2010-07-22       Impact factor: 17.367

Review 8.  Diabetes mellitus, a microRNA-related disease?

Authors:  Claudiane Guay; Elodie Roggli; Valeria Nesca; Cécile Jacovetti; Romano Regazzi
Journal:  Transl Res       Date:  2011-02-04       Impact factor: 7.012

9.  MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue.

Authors:  Sashwati Roy; Savita Khanna; Syed-Rehan A Hussain; Sabyasachi Biswas; Ali Azad; Cameron Rink; Surya Gnyawali; Shani Shilo; Gerard J Nuovo; Chandan K Sen
Journal:  Cardiovasc Res       Date:  2009-01-15       Impact factor: 10.787

Review 10.  Relevance of miR-21 in HIV and non-HIV-related lymphomas.

Authors:  Durairaj Sekar; Villianur Ibrahim Hairul Islam; Krishnaraj Thirugnanasambantham; Subramanian Saravanan
Journal:  Tumour Biol       Date:  2014-06-25
View more
  2 in total

1.  FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells.

Authors:  Shibnath Ghatak; Vincent C Hascall; Roger R Markwald; Suniti Misra
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

2.  Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance.

Authors:  Shibnath Ghatak; Vincent C Hascall; Nikos Karamanos; Roger R Markwald; Suniti Misra
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.